Overwhelming Success of First International NASH Day Paves Way for a Promising Edition In 2019

Preferisci Informazione.News su Google

"The world's response to International NASH Day smashed even our highest expectations - and we are deeply grateful," said Pascaline Clerc, PhD, U.S. Campaign Manager for The NASH Education Program™. "But this first convening of the world's top nonalcoholic steatohepatitis (NASH) medical and research experts, providers, patients and the public is just the first step in what we believe will be a growing global phenomenon that harnesses the world's scientific strength in one place to fully address, and beatthissilent killer."

The NASH Education Program™, which has successfully launched, led and coordinated the global effort for this first-of-its-kind edition, is proud of the magnitude reached in terms of:

Early metrics on the first-ever International NASH Day's global rollout shows:

To replay the web TV program that went live for the 1^st International NASH Day 

Subtitles can be easily selected via the YouTube player interface (bottom right of the YouTube player screen). Seven content-rich programs are available in high definition video:

Access to photosand tomedia coverage review  

For a first look at what happened on the 1^st International NASH Day, go here.

And for an early look at media coverage, go here.

Special thanks 

Key opinion leaders from several countries across the globe have been involved in the preparation of several local conferences, in collaboration with The NASH Education Program™. We want to commend specifically:

Social networks 

Official hashtags are #NASHday #MacLiver

Global supporters: non-profit organizations and benefactors 

Local benefactor 

About NASH 

NASH, or nonalcoholic steatohepatitis, is a metabolic disease characterized by the accumulation of fat in the liver, along with inflammation and the degeneration of liver cells. The disease is associated with long-term risk of progression into diminished liver functionality, leading to non-alcoholic cirrhosis, liver insufficiency and possibly even liver cancer. It also is associated with an increased risk of cardiovascular diseases which represent the leading cause of mortality for NASH patients. The rise of NASH is connected to type 2 diabetes and obesity epidemics that are growing globally.

About TheNASH Education Program™

Formed in 2017, the non-profit NASH Education Program is designed to educate and activate the patient, medical and research communities against the public health crisis that NASH presents. It is estimated that between 20 and 30% of the global population is afflicted with NAFLD, and between 5 and 12% suffer from its severe form, NASH, putting them at risk for cardiovascular events, cirrhosis or liver cancer.

The NASH Education Program™ defines and drives initiatives in collaboration with an independent scientific committee composed of four international key opinion leaders in the hepatic and metabolic disease ecosystems in the U.S. and Europe. To learn more, visit http://www.the-nash-education-program.com.

Contact 

The NASH Education Program™

[email protected]

Pascaline Clerc - U.S. Campaign Manager, [email protected]

Press Relations  

For the EU: Ulysse Communication, Bruno Arabian, [email protected] , +33-687884726

For the US: SuSiglo Media, Maritza Puello, [email protected] , +1-917-886-349